Browse > Article
http://dx.doi.org/10.4332/KJHPA.2021.31.4.409

Lessons from Using Opioid to the Treatment of Chronic Pain: Focus on Experiences with the Organization for Economic Cooperation and Development Countries  

IM, Jeehye (Review and Assessment Research Department, Health Insurance Review and Assessment Service)
Cho, Jae Young (Department of Big Data Management, National Health Insurance Service)
Publication Information
Health Policy and Management / v.31, no.4, 2021 , pp. 409-422 More about this Journal
Abstract
The growing use of prescription analgesic opioids has rapidly escalated the treatment of chronic pain since the 1990s; however, it is also highly needed to control opioid-related issues, including opioids misuse, abuse, and addiction. In 2018, Organization for Economic Cooperation and Development (OECD) secretariat administered the survey on opioids use and policies to OECD countries and presented it at the Health Committee meeting of December 2018. This study aimed to review the opioids use in OECD countries and their policies to prevent and reduce associated harms, also seek the available policy lessons from OECD countries. More recently, opioids prescribing rate have been increased 14.7% between 2011-2013 and 2014-2016 and steadily focused on the main substance misused and abused in Korea. In addition, policy efforts have contributed to developing a guideline for prescribing opioids to steer the appropriate use of prescription analgesic opioids since 2000 in Korea, so it is not enough to control opioids compared with other OECD countries. Therefore, taking a people-centered and public health perspective, it will consider the health system policies and interventions at a national level to improve their preparation and approach to control opioid-related issues.
Keywords
Prescription analgesic opioid; Treatment of chronic pain; Opioid-related Issues; OECD countries; Health system policies and interventions;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Choi CH, Lee ST. A study on the reorganization of the Narcotic Control Act. Sejong: Korean Legislation Research Institute; 2007.
2 Yu SY, Cho H, Kang HA, Kim S. A study on the policy implication on the management of narcotics distribution for medical use. Korean J Clin Pharm 2015;25(4):280-285. DOI: https://doi.org/10.0000/kjcp.2015.25.4.280.   DOI
3 Han JR. Reporting side effects of 'Tramadol' over the past 5 years and 6 months. DailyMediparm [Internet]. 2019 Oct 8 [cited 2021 Nov 11]. Available from: http://www.dailymedipharm.com/news/articleView.html?idxno=47974.
4 Ministry of Food and Drug Safety. The reporting system through the "Integrated Narcotics Management System" will be implemented on May 18 [Internet]. Cheongju: Ministry of Food and Drug Safety; 2018 [cited 2021 Nov 11]. Available from: https://www.mfds.go.kr/brd/m_99/view.do?seq=42004&srchFr=&srchTo=&srchWord=%EA%B0%80%EC%9D%B4%EB%93%9C%EB%9D%BC%EC%9D%B8&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=2.
5 Baek JH, Kwon HY, Cho YS, Kim HS, Kwon KH. The study of reasonable management of controlled drugs through a comparative analysis of management guidelines both domestic and abroad. J Korean Soc Health Syst Pharm 2013;30(2):141-156. DOI: https://doi.org/10.32429/jkshp.2013.30.2.005.   DOI
6 Ministry of Food and Drug Safety. Criteria for measures to prevent misuse of narcotics. Cheongju: Ministry of Food and Drug Safety; 2021.
7 Office for Government Policy Coordination; Ministry of Food and Drug Safety; Korea Customs Service; Supreme Prosecutors' Office of the Republic of Korea; Korean National Police Agency; Korea Coast Guard. We will make Korea safety from drug [Internet]. Cheongju: Ministry of Food and Drug Safety; 2020 [cited 2021 Nov 11]. Available from: https://www.mfds.go.kr/brd/m_99/down.do?brd_id=ntc0021&seq=45112&data_tp=A&file_seq=2.
8 Choi S. A survey is conducted on Tramadol, a similar drug. MedicalTimes [Internet]. 2021 Jul 20 [cited 2021 Nov 11]. Available from: http://m.medicaltimes.com/News/1141820.
9 Ministry of Food and Drug Safety. The letter of drug safety (2016. 9. 9.). Cheongju: Ministry of Food and Drug Safety; 2016.
10 Korean Statistical Information Service. Current status of medical drugs. Cheongju: Ministry of Food and Drug Safety; 2021.
11 Choi SJ, Kim EM. Tramadol is subject to control overseas: a domestic pain relieve, why? PharmNews [Internet]. 2019 Dec 11 [cited 2021 Nov 11]. Available from: https://www.pharmnews.com/news/articleView.html?idxno=99602.
12 Organization for Economic Cooperation and Development. OECD health policy studies: addressing problematic opioid use in OECD countries [Internet]. Paris: Organization for Economic Cooperation and Development; 2019 [cited 2021 Nov 11]. Available from: https://www.oecd.org/els/health-systems/opioids.htm.
13 Musto DF. The American disease: origins of narcotic control. 3rd ed. New York (NY): Oxford University Press; 1999.
14 Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006;81(2):103-107. DOI: https://doi.org/10.1016/j.drugalcdep.2005.05.009.   DOI
15 Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999;353(9165):1695-1700. DOI: https://doi.org/10.1016/S0140-6736(99)01310-0.   DOI
16 Manchikanti L. Health care reform in the United States: radical surgery needed now more than ever. Pain Physician 2008;11(1):13-42. DOI: https://doi.org/10.36076/ppj.2008/11/13.   DOI
17 Streltzer J, Johansen L. Prescription drug dependence and evolving beliefs about chronic pain management. Am J Psychiatry 2006;163(4):594-598. DOI: https://doi.org/10.1176/appi.ajp.163.4.594.   DOI
18 Choi HY, Lee EK. Market analysis of narcotic analgesics in Korea using HIRA claims data. J Korean Acad Soc Manag Care Pharm 2015;4(1):31-37.
19 Streltzer J, Kosten TR. Methadone maintenance therapy and chronic pain. JAMA 2003;290(18):2403. DOI: https://doi.org/10.1001/jama.290.18.2403-a.   DOI
20 Ballantyne JC, LaForge SK. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007;129(3):235-255. DOI: https://doi.org/10.1016/j.pain.2007.03.028.   DOI
21 Portenoy RK, Payne R. Acute and chronic pain. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, editors. Substance abuse: a comprehensive textbook. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkens; 2005. pp. 863-904.
22 Dowell D, Arias E, Kochanek K, Anderson R, Guy GP Jr, Losby JL, et al. Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015. JAMA 2017;318(11):1065-1067. DOI: https://doi.org/10.1001/jama.2017.9308.   DOI
23 Cho GH. Opioid misuse, are we in safe zone? [Internet]. Seoul: National Evidence-based Healthcare Collaborating Agency; 2019 [cited 2021 Nov 11]. Available from: http://hineca.kr/1976.
24 Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N Engl J Med 2017;377(4):391-394. DOI: https://doi.org/10.1056/NEJMsr1706626.   DOI
25 Hosztafi S. The history of heroin. Acta Pharm Hung 2001;71(2):233-242.
26 Field MJ, Cassel CK. Approaching death: improving care at the end of life. Washington (DC): National Academy Press; 1997.
27 University of Bristol. Doctor should avoid co-prescribing benzodiazepines to opioid dependent patients due to increase in overdose death [Internet]. Bristol: University of Bristol; 2019 [cited 2021 Nov 11]. Available from: https://www.bristol.ac.uk/news/2019/november/benzodiazepines-.html.
28 Chiu AS, Healy JM, DeWane MP, Longo WE, Yoo PS. Trainees as agents of change in the opioid epidemic: optimizing the opioid prescription practices of surgical residents. J Surg Educ 2018;75(1):65-71. DOI: https://doi.org/10.1016/j.jsurg.2017.06.020.   DOI
29 Webster F, Bremner S, Oosenbrug E, Durant S, McCartney CJ, Katz J. From opiophobia to overprescribing: a critical scoping review of medical education training for chronic pain. Pain Med 2017;18(8):1467-1475. DOI: https://doi.org/10.1093/pm/pnw352.   DOI
30 Kroenke K, Cheville A. Management of chronic pain in the aftermath of the opioid backlash. JAMA 2017;317(23):2365-2366. DOI: https://doi.org/10.1001/jama.2017.4884.   DOI
31 Substance Abuse and Mental Health Services Administration. DASIS report: treatment admissions involving narcotic pain killers [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2002 [cited 2021 Nov 11]. Available from: http://www.oas.samhsa.gov/2k4/painTX/painTX.htm.
32 Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ 2017;189(18):E659-E666. DOI: https://doi.org/10.1503/cmaj.170363.   DOI
33 Ministry of Food and Drug Safety. Guidelines for safe use of medical drugs. Cheongju: Ministry of Food and Drug Safety; 2021.
34 Cicero TJ, Ellis MS, Kasper ZA. Psychoactive substance use prior to the development of iatrogenic opioid abuse: a descriptive analysis of treatment-seeking opioid abusers. Addict Behav 2017;65:242-244. DOI: https://doi.org/10.1016/j.addbeh.2016.08.024.   DOI
35 Kim DY. Narcotic analgesics. In: The Korean Pain Society, editor. Textbook of pain medicine. 4th ed. Paju: Shinwon Medicine Book; 2012. pp. 469-480.
36 Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16(5):405-416. DOI: https://doi.org/10.1037/a0013628.   DOI
37 Ministry of Food and Drug Safety. Narcotic safety management annual report. Cheongju: Ministry of Food and Drug Safety; 2020. pp. 40-48.
38 Substance Abuse and Mental Health Services Administration. Emergency department trends from the Drug Abuse Warning Network: final estimates 1995-2002. Rockville (MD): Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2003.
39 Schnoll SH, Weaver MF. Addiction and pain. Am J Addict 2003;12(s2):S27-S35. DOI: https://doi.org/10.1111/j.1521-0391.2003.tb00554.x.   DOI
40 Breitbart W, Passik S, McDonald MV, Rosenfeld B, Smith M, Kaim M, et al. Patient-related barriers to pain management in ambulatory AIDS patients. Pain 1998;76(1-2):9-16. DOI: https://doi.org/10.1016/s0304-3959(98)00018-9.   DOI
41 Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008;148(2):94-101. DOI: https://doi.org/10.7326/0003-4819-148-2-200801150-00004.   DOI
42 McQuay H. Opioids in pain management. Lancet 1999;353(9171):2229-2232. DOI: https://doi.org/10.1016/S0140-6736(99)03528-X.   DOI
43 Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis. BMJ 2017;359:j4792. DOI: https://doi.org/10.1136/bmj.j4792.   DOI
44 Council of Economic Advisers. The underestimated cost of the opioid crisis. Washington (DC): Council of Economic Advisers; 2017.
45 Stanek JJ, Renslow MA, Kalliainen LK. The effect of an educational program on opioid prescription patterns in hand surgery: a quality improvement program. J Hand Surg Am 2015;40(2):341-346. DOI: https://doi.org/10.1016/j.jhsa.2014.10.054.   DOI
46 Alford DP, Zisblatt L, Ng P, Hayes SM, Peloquin S, Hardesty I, et al. SCOPE of pain: an evaluation of an opioid risk evaluation and mitigation strategy continuing education program. Pain Med 2016;17(1):52-63. DOI: https://doi.org/10.1111/pme.12878.   DOI
47 Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ 2017;357:j1550. DOI: https://doi.org/10.1136/bmj.j1550.   DOI
48 Organization for Economic Cooperation and Development. Fast Track Paper: antimicrobial resistance in long-term care facilities: DELSA/HEA(2020)26. Paris: Organization for Economic Cooperation and Development; 2020.
49 Bao Y, Wen K, Johnson P, Jeng PJ, Meisel ZF, Schackman BR. Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions. Health Aff (Millwood) 2018;37(10):1596-1604. DOI: https://doi.org/10.1377/hlthaff.2018.0512.   DOI
50 Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health 2015;36:559-574. DOI: https://doi.org/10.1146/annurev-publhealth-031914-122957.   DOI
51 Reidenberg MM, Willis O. Prosecution of physicians for prescribing opioids to patients. Clin Pharmacol Ther 2007;81(6):903-906. DOI: https://doi.org/10.1038/sj.clpt.6100127.   DOI
52 Patrick SW, Fry CE, Jones TF, Buntin MB. Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff (Millwood) 2016;35(7):1324-1332. DOI: https://doi.org/10.1377/hlthaff.2015.1496.   DOI
53 Pardo B. Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction 2017;112(10):1773-1783. DOI: https://doi.org/10.1111/add.13741.   DOI
54 Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014;160(1):38-47. DOI: https://doi.org/10.7326/0003-4819-160-1-201401070-00732.   DOI
55 Ministry of Food and Drug Safety. Announcement of the results of the first joint inspection of medical drug management in 2021 [Internet]. Cheongju: Ministry of Food and Drug Safety; 2021 [cited 2021 Nov 11]. Available from: https://www.mfds.go.kr/brd/m_99/view.do?seq=45002.
56 University Health Network. Chronic pain & opioid stewardship [Internet]. Toronto (ON): Project ECHO; 2018 [cited 2021 Nov 11]. Available from: https://uhn.echoontario.ca/Our-Programs/ChronicPain.
57 Worley J. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research. Issues Ment Health Nurs 2012;33(5):319-328. DOI: https://doi.org/10.3109/01612840.2011.654046.   DOI
58 Bohnert AS, Guy GP Jr, Losby JL. Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention's 2016 opioid guideline. Ann Intern Med 2018;169(6):367-375. DOI: https://doi.org/10.7326/M18-1243.   DOI
59 Christie C, Baker C, Cooper R, Kennedy PJ, Madras B; Florida Attorney General Pam Bondi. The President's Commission on combating drug addiction and the opioid crisis. Washington (DC): The White House; 2017.
60 Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. JAMA Netw Open 2018;1(2):e180217. DOI: https://doi.org/10.1001/jamanetworkopen.2018.0217.   DOI
61 British Colombia Ministry of Health. A guideline for the clinical management of opioid use disorder [Internet]. Vancouver (BC): British Columbia Ministry of Health; 2017 [cited 2021 Nov 11]. Available from: http://www.bccsu.ca/care-guidance-publications.
62 Cho YS, Lee JY, Kim HS, Kwon K. Trends in the consumption of opioid analgesics in a tertiary care hospital from 2000 to 2012. Yakhak Hoeji 2014;58(4):268-276.
63 Heath S. Using patient-centered care to address opioid use, prescribing: multidisciplinary team-based care and patient-centered care are at the core of the HHS strategy for managing opioid and pain management care [Internet]. Danvers (MA): Patient Engagement Hit; 2019 [cited 2021 Nov 11]. Available from: https://patientengagementhit.com/news/using-patient-centeredcare-to-address-opioid-use-prescribing.
64 Yoo SI. Temporarily allowed non-face-to-face treatment platform: it turns into a hotbed for drug and antibiotic shopping. Kukminilbo. 2021 Nov 1; L06, Special.
65 Rutkow L, Chang HY, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida's prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Intern Med 2015;175(10):1642-1649. DOI: https://doi.org/10.1001/jamainternmed.2015.3931.   DOI
66 National Academy of Medicine of Korea. Guidance for prevention of opioid analgesics abuse. Seoul: National Academy of Medicine of Korea; 2021.
67 Lee JC. The pharmacologic management of chronic non-cancer pain. Korean J Fam Pract 2020;10(3):164-175. DOI: https://doi.org/10.21215/kjfp.2020.10.3.164.   DOI
68 Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry 2019;24(12):1868-1883. DOI: https://doi.org/10.1038/s41380-018-0094-5.   DOI
69 Reifler LM, Droz D, Bailey JE, Schnoll SH, Fant R, Dart RC, et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Med 2012;13(3):434-442. DOI: https://doi.org/10.1111/j.1526-4637.2012.01327.x.   DOI
70 European Monitoring Centre for Drugs and Drug Addiction. Annual report on the state of the drugs problem in the European Union, 2000 [Internet]. Washington (DC): U.S. Department of Justice, Office of Justice Programs; 2000 [cited 2021 Nov 11]. Available from: https://www.ncjrs.gov/App/Publications/abstract.aspx?ID=186282.
71 Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, et al. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain 2007;23(8):648-660. DOI: https://doi.org/10.1097/AJP.0b013e318125c5e8.   DOI
72 United Nations Office on Drugs and Crime. World drug report 2018 [Internet]. Vienna: United Nations Office on Drugs and Crime; 2018 [cited 2021 Nov 11]. Available from: https://www.unodc.org/wdr2018.
73 Canadian Institute for Health Information. Types of opioid harms in Canadian hospitals: comparing Canada and Australia. Ottawa (ON): Canadian Institute for Health Information; 2018.
74 Ye X, Sutherland J, Henry B, Tyndall M, Kendall PR. At-a-glance: impact of drug overdose-related deaths on life expectancy at birth in British Columbia. Health Promot Chronic Dis Prev Can 2018;38(6):248-251. DOI: https://doi.org/10.24095/hpcdp.38.6.05.   DOI
75 Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009;2009(3):CD002209. DOI: https://doi.org/10.1002/14651858.CD002209.pub2.   DOI
76 Special Advisory Committee on the Epidemic of Opioid Overdoses. National report: apparent opioid-related deaths in Canada (January 2016 to December 2017) Web-based report [Internet]. Ottawa (ON): Public Health Agency of Canada; 2018 [cited 2021 Nov 11]. Available from: https://www.canada.ca/en/public-health/services/publications/healthy-living/national-report-apparent-opioid-related-deaths-released-march-2018.html.
77 Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep 2016;65(50-51):1445-1452. DOI: https://doi.org/10.15585/mmwr.mm655051e1.   DOI
78 Lin DH, Jones CM, Compton WM, Heyward J, Losby JL, Murimi IB, et al. Prescription drug coverage for treatment of low back pain among US Medicaid, Medicare advantage, and commercial insurers. JAMA Netw Open 2018;1(2):e180235. DOI: https://doi.org/10.1001/jamanetworkopen.2018.0235.   DOI
79 Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev 2016;(5):CD011117. DOI: https://doi.org/10.1002/14651858.CD011117.pub2.   DOI
80 Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend 2009;105(1-2):9-15. DOI: https://doi.org/10.1016/j.drugalcdep.2009.05.021.   DOI
81 Strang J, McDonald R. Preventing opioid overdose deaths with take-home naloxone. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2016. DOI: https://doi.org/10.2810/357062.
82 Booth M. Opium: a history. New York (NY): St. Martin's Press; 1996.